NewslettersMammary Cell NewsUncategorizedmTOR Inhibition and Trastuzumab-Emtansine (T-DM1) in HER2-Positive Breast CancerBy Justin.choi - March 31, 2022050Everolimus in combination with T-DM1 showed strong antitumor effects in HER2-positive breast cancer, both in vitro and in vivo.[Molecular Cancer Research] 6445212 AAAAAAAA items 1 apa 0 default asc 1 173497 https://www.stemcellsciencenews.com/wp-content/plugins/zotpress/Abstract